C12N2710/16064

Live attenuated infectious laryngotracheitis virus (ILTV) vaccines and preparation thereof

This disclosure describes a modified live infectious laryngotracheitis virus (ILTV) developed from a strain of ILTV grown at a reduced incubation temperature, vaccines that include the modified live ILTV, methods for producing the live modified ILTV, and methods that include administering the modified ILTV to a subject.